These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 25550557

  • 1. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
    Kim K, Wu HG, Jeon SR.
    Anticancer Res; 2015 Jan; 35(1):245-53. PubMed ID: 25550557
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY, Lee SW, Hong JP, Chang SE, Choe H, Choi J.
    Cancer Lett; 2009 Oct 08; 283(2):135-42. PubMed ID: 19380191
    [Abstract] [Full Text] [Related]

  • 3. Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells.
    Wu J, Zuo F, Du J, Wong PF, Qin H, Xu J.
    Mol Med Rep; 2013 Aug 08; 8(2):597-602. PubMed ID: 23807305
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
    Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM, Harari PM.
    Cancer Res; 2005 Apr 15; 65(8):3328-35. PubMed ID: 15833866
    [Abstract] [Full Text] [Related]

  • 5. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
    Ishitsuka A, Fujine E, Mizutani Y, Tawada C, Kanoh H, Banno Y, Seishima M.
    Int J Mol Med; 2014 Oct 15; 34(4):1169-74. PubMed ID: 25109763
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
    Li P, Zhang Q, Torossian A, Li ZB, Xu WC, Lu B, Fu S.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):e391-7. PubMed ID: 22414288
    [Abstract] [Full Text] [Related]

  • 7. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):223-9. PubMed ID: 15850925
    [Abstract] [Full Text] [Related]

  • 8. Chrysophanic acid blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway.
    Lee MS, Cha EY, Sul JY, Song IS, Kim JY.
    Phytother Res; 2011 Jun 01; 25(6):833-7. PubMed ID: 21089180
    [Abstract] [Full Text] [Related]

  • 9. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 10. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
    Gallardo G, Tabraue C, Quintana J, López-Blanco F, Cabrera J, Díaz R, Estévez F, Ruiz de Galarreta CM, Fanjul LF, Santana P.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 01; 46(7):1305-12. PubMed ID: 11075960
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S, Horváth G, Knuechel-Clarke R, Hofstaedter F, Szöllosi J, Brockhoff G.
    Exp Cell Res; 2005 Apr 01; 304(2):604-19. PubMed ID: 15748904
    [Abstract] [Full Text] [Related]

  • 12. Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib.
    Kim JC, Ali MA, Nandi A, Mukhopadhyay P, Choy H, Cao C, Saha D.
    Indian J Biochem Biophys; 2005 Dec 01; 42(6):358-65. PubMed ID: 16955736
    [Abstract] [Full Text] [Related]

  • 13. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P, Rojo F, Cassia R, Moreno-Bueno G, Di Cosimo S, Tabernero J, Guzmán M, Rodriguez S, Arribas J, Palacios J, Baselga J.
    Clin Cancer Res; 2004 Oct 01; 10(19):6487-501. PubMed ID: 15475436
    [Abstract] [Full Text] [Related]

  • 14. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Oct 01; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 15. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH, Szczepanski MJ, Lee YJ.
    J Cell Biochem; 2009 Apr 15; 106(6):1113-22. PubMed ID: 19229860
    [Abstract] [Full Text] [Related]

  • 16. Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
    Fattah OM, Cloutier SM, Kündig C, Felber LM, Gygi CM, Jichlinski P, Leisinger HJ, Gauthier ER, Mach JP, Deperthes D.
    Int J Cancer; 2006 Nov 15; 119(10):2455-63. PubMed ID: 16858684
    [Abstract] [Full Text] [Related]

  • 17. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML, Kruyt FA, Rodriguez JA, Giaccone G.
    Clin Cancer Res; 2003 Jun 15; 9(6):2316-26. PubMed ID: 12796401
    [Abstract] [Full Text] [Related]

  • 18. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
    Liu H, Li L, Li XQ, Liu XJ, Zhen YS.
    Anticancer Drugs; 2009 Jan 15; 20(1):41-9. PubMed ID: 19342999
    [Abstract] [Full Text] [Related]

  • 19. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C, Zhu Q, Wu Z, Yin Y, Kang D, Lu S, Liu P.
    J Cell Physiol; 2018 Feb 15; 233(2):1104-1119. PubMed ID: 28422286
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin").
    Fukutome M, Maebayashi K, Nasu S, Seki K, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):528-36. PubMed ID: 16965995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.